Graf Akcie RDHL (Redhill Biopharma Ltd.). Diskuze k akciím RDHL. Aktuální informace RDHL.

Základní informace o společnosti Redhill Biopharma Ltd. (Akcie RDHL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie RDHL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$6.291$8.36$4.007$0.101$0.003$7.014$0.012$0.01
Cost Of Goods Sold$2.259$2.837$2.126--$1.05--
Gross Profit$4.032$5.523$1.881$0.101$0.003$5.964$0.012$0.01
Research And Development Expenses$17.419$24.862$32.969$25.241$17.771$12.7$8.1$6.45
SG&A Expenses$29.814$19.992$20.039$5.403$4.134$4.011$2.684$2.6
Other Operating Income Or Expenses--$-0.845-$-0.1$0.1--
Operating Expenses$49.492$47.691$55.979$30.644$22.005$17.661$10.784$9.05
Operating Income$-43.201$-39.331$-51.972$-30.543$-22.002$-10.647$-10.772$-9.04
Total Non-Operating Income/Expense$0.897$0.511$6.428$1.173$0.912$-0.064$0.144$-1.28
Pre-Tax Income$-42.304$-38.82$-45.544$-29.37$-21.09$-10.711$-10.628$-10.32
Income Taxes--------
Income After Taxes$-42.304$-38.82$-45.544$-29.37$-21.09$-10.711$-10.628$-10.32
Other Income--------
Income From Continuous Operations$-42.304$-38.82$-45.544$-29.37$-21.09$-10.711$-10.628$-10.326
Income From Discontinued Operations--------
Net Income$-42.304$-38.82$-45.544$-29.37$-21.09$-10.711$-10.628$-10.32
EBITDA$-42.204$-39.241$-51.891$-30.499$-21.966$-10.62$-10.748$-9.02
EBIT$-43.201$-39.331$-51.972$-30.543$-22.002$-10.647$-10.772$-9.04
Basic Shares Outstanding3023181311965
Shares Outstanding3023181311965
Basic EPS$-1.40$-1.70$-2.60$-2.29$-1.90$-1.20$-1.70$-2.00
EPS - Earnings Per Share$-1.40$-1.70$-2.60$-2.29$-1.90$-1.30$-1.70$-2.00
# 2020 2019 2018 2017 2016 2015
Current Ratio5.01265.47044.368212.661510.973915.1273
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin64.091666.064646.942910010085.0299
Operating Margin-686.7112-470.4665-1297.03-30240.59-733399.9-151.7964
EBIT Margin-686.7112-470.4665-1297.03-30240.59-733399.9-151.7964
EBITDA Margin-670.8631-469.39-1295.009-30197.03-732200-151.4115
Pre-Tax Profit Margin-672.4528-464.3541-1136.611-29079.21-703000-152.7089
Net Profit Margin-672.4528-464.3541-1136.611-29079.21-703000-152.7089
Asset Turnover0.08490.1340.06990.0014-0.2431
Inventory Turnover Ratio1.20033.68923.2557---
Receiveable Turnover5.17358.72652.62241.0202--
Days Sales In Receivables70.551641.8266139.1864357.7723--
ROE - Return On Equity-70.5043-75.8411-101.0629-46.8414-35.105-42.8252
Return On Tangible Equity-98.2101-84.6379-114.4897-51.885-39.0433-47.8255
ROA - Return On Assets-57.0912-62.2006-79.4238-39.5758-31.5586-37.1188
ROI - Return On Investment-70.5043-75.8411-101.0629-46.8414-35.105-42.8252
Book Value Per Share1.70121.80432.11873.80084.72642.846
Operating Cash Flow Per Share0.11821.0448-0.3366-0.5902-0.2065-0.0497
Free Cash Flow Per Share0.11361.052-0.3382-0.5955-0.1998-0.0555